Literature DB >> 19892177

Refolding solubilized inclusion body proteins.

Richard R Burgess1.   

Abstract

The vast majority of protein purification is now done with cloned, recombinant proteins expressed in a suitable host. The predominant host is Escherichia coli. Many, if not most, expressed proteins are found in an insoluble form called an inclusion body (IB). Since the target protein is often relatively pure in a washed IB, the challenge is not so much to purify the target, but rather to solubilize an IB and refold the protein into its native structure, regaining full biological activity. While many of the operations of this process are quite general (expression, cell disruption, IB isolation and washing, and IB solubilization), the precise conditions that give efficient refolding differ for each protein. This chapter describes the main techniques and strategies for achieving successful refolding.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19892177     DOI: 10.1016/S0076-6879(09)63017-2

Source DB:  PubMed          Journal:  Methods Enzymol        ISSN: 0076-6879            Impact factor:   1.600


  57 in total

1.  Expression of soluble and functional full-length human matrix metalloproteinase-2 in Escherichia coli.

Authors:  Andrezza N Gonçalves; Cesar A Meschiari; William G Stetler-Stevenson; M Cristina Nonato; Cleidson P Alves; Enilza M Espreafico; Raquel F Gerlach
Journal:  J Biotechnol       Date:  2011-10-05       Impact factor: 3.307

2.  Experimental optimization of protein refolding with a genetic algorithm.

Authors:  Bernd Anselment; Danae Baerend; Elisabeth Mey; Johannes Buchner; Dirk Weuster-Botz; Martin Haslbeck
Journal:  Protein Sci       Date:  2010-11       Impact factor: 6.725

3.  Strategies for production of active eukaryotic proteins in bacterial expression system.

Authors:  Orawan Khow; Sunutcha Suntrarachun
Journal:  Asian Pac J Trop Biomed       Date:  2012-02

4.  Biochemical and Phylogenetic Study of SltF, a Flagellar Lytic Transglycosylase from Rhodobacter sphaeroides.

Authors:  Mariela García-Ramos; Javier de la Mora; Teresa Ballado; Laura Camarena; Georges Dreyfus
Journal:  J Bacteriol       Date:  2018-09-24       Impact factor: 3.490

5.  Characterization of secondary structure and lipid binding behavior of N-terminal saposin like subdomain of human Wnt3a.

Authors:  Aparna Krishnamoorthy; Andrzej Witkowski; Jesse J Tran; Paul M M Weers; Robert O Ryan
Journal:  Arch Biochem Biophys       Date:  2017-07-25       Impact factor: 4.013

6.  Highly efficient production of soluble proteins from insoluble inclusion bodies by a two-step-denaturing and refolding method.

Authors:  Zhong Yang; Linlin Zhang; Yan Zhang; Ting Zhang; Yanye Feng; Xiuxiu Lu; Wenxian Lan; Jufang Wang; Houming Wu; Chunyang Cao; Xiaoning Wang
Journal:  PLoS One       Date:  2011-07-29       Impact factor: 3.240

Review 7.  Immunogenicity Risk Assessment for an Engineered Human Cytokine Analogue Expressed in Different Cell Substrates.

Authors:  Paul Chamberlain; Bonita Rup
Journal:  AAPS J       Date:  2020-04-14       Impact factor: 4.009

8.  Monoclonal antibody preparation and expression profile analysis of a novel hepatoma associated gene.

Authors:  Yanhong Liu; Jie Song; Yuehui Li; Yanjie Zhao; Qiang Ju; Guohua Zhou; Guancheng Li
Journal:  Pathol Oncol Res       Date:  2013-11-09       Impact factor: 3.201

9.  Enzyme-linked immunosorbent assay using recombinant SAG1 antigen to detect Toxoplasma gondii-specific immunoglobulin G antibodies in human sera and saliva.

Authors:  Nouha Chahed Bel-Ochi; Aïda Bouratbine; Mohamed Mousli
Journal:  Clin Vaccine Immunol       Date:  2013-01-23

10.  Use of protein folding reagents.

Authors:  P T Wingfield
Journal:  Curr Protoc Protein Sci       Date:  2001-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.